Product Information
LANSOPRAZOLE DR 30 MG ODT is a generic product labeled by NorthStar Rx LLC, priced at $2.2103 per EA under NDC 16714018602. Its NADAC has been published 229 times since Apr 6, 2022.
FDA first approved this application on Feb 1, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the lansoprazole market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
30 mg/1
Manufacturer
NorthStar Rx LLCNDC
16714018602
Classification
Generic
Dosage Form
TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
LANSOPRAZOLEApproval Type
Generic (ANDA)
FDA Application
ANDA210465FDA Approved
2/1/2021
TE Code
AB
On Market Since
12/10/2021
Pharmacological Classes
Price Statistics
The NADAC for LANSOPRAZOLE DR 30 MG ODT has been published 229 times since Apr 6, 2022, and over the history we have for it it has declined 60.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.2103 per EA |
|---|---|
| All-time high | $5.5211 (Apr 13, 2022) |
| All-time low | $1.8384 (Apr 22, 2026) |
| 52-week high | $2.8016 |
| 52-week low | $1.8384 |
| Median price | $2.8016 |
| Average price | $3.2421 |
| Largest weekly change | +39.6% (Aug 23, 2023) |
| Weeks tracked | 229 |
| Tracking since | Apr 6, 2022 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the lansoprazole market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of LANSOPRAZOLE DR 30 MG ODT?
The current National Average Drug Acquisition Cost (NADAC) for LANSOPRAZOLE DR 30 MG ODT, manufactured by NorthStar Rx LLC, is $2.2103 per EA (NDC 16714018602), effective Aug 19, 2026.
How has the price of LANSOPRAZOLE DR 30 MG ODT changed over time?
Over the history we have for it, the NADAC for LANSOPRAZOLE DR 30 MG ODT has declined 60.0%. It has been tracked across 229 weekly CMS publications since Apr 6, 2022.
What are the highest and lowest recorded NADAC prices for LANSOPRAZOLE DR 30 MG ODT?
Since Apr 6, 2022, the NADAC for LANSOPRAZOLE DR 30 MG ODT has ranged from a low of $1.8384 (Apr 22, 2026) to a high of $5.5211 (Apr 13, 2022), with a median of $2.8016 per EA.
Are there cheaper alternatives to LANSOPRAZOLE DR 30 MG ODT?
No other NADAC-published product currently shares the active ingredient and strength of LANSOPRAZOLE DR 30 MG ODT in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures LANSOPRAZOLE DR 30 MG ODT?
LANSOPRAZOLE DR 30 MG ODT (NDC 16714018602) is labeled by NorthStar Rx LLC, and CMS classifies it as a generic product.